Literature DB >> 12691151

The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma.

A E Guppy1, N C Tebbutt, A Norman, D Cunningham.   

Abstract

The use of routine surveillance computed tomography (CT) scans in the follow-up of patients with diffuse large B-cell lymphoma may allow the detection of early asymptomatic relapse. On this basis, CT scans are frequently included in follow-up schedules, but the utility of this investigation in this setting has never been determined. This study evaluated the effectiveness of routine surveillance CT scans performed 3 and 12 months after completion of chemotherapy in patients with diffuse large B-cell lymphoma who had achieved a complete response. One hundred and seventeen patients with diffuse large B-cell lymphoma achieved complete remission at the Royal Marsden Hospital using first line combination chemotherapy between January 1992 and January 2000. The median follow-up was 4.6 years and 35 patients subsequently relapsed. Relapse was associated with the development of new symptoms and/or signs in 86% of cases. Only 5.7% of relapses were detected in asymptomatic patients using surveillance CT scans. Routine surveillance CT scans are of limited value in detecting asymptomatic early relapse and other approaches are required in order to identify patients destined to relapse at an earlier stage.

Entities:  

Mesh:

Year:  2003        PMID: 12691151     DOI: 10.1080/1042819021000040323

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  11 in total

1.  Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

Authors:  Carrie A Thompson; Herve Ghesquieres; Matthew J Maurer; James R Cerhan; Pierre Biron; Stephen M Ansell; Catherine Chassagne-Clément; David J Inwards; Thérèse Gargi; Patrick B Johnston; Emmanuelle Nicolas-Virelizier; William R Macon; Marie Peix; Ivana N Micallef; Catherine Sebban; Grzegorz S Nowakowski; Luis F Porrata; George J Weiner; Thomas E Witzig; Thomas M Habermann; Brian K Link
Journal:  J Clin Oncol       Date:  2014-09-29       Impact factor: 44.544

Review 2.  Surveillance Scans in Lymphoma: Friend or Foe?

Authors:  Tycel Phillips; Jessica Mercer
Journal:  Curr Treat Options Oncol       Date:  2017-02

Review 3.  Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.

Authors:  Jonathon B Cohen; Madhusmita Behera; Carrie A Thompson; Christopher R Flowers
Journal:  Blood       Date:  2016-12-12       Impact factor: 22.113

4.  Total estimated effective doses from radiologic imaging modalities of children with cancer: a single center experience.

Authors:  Derya Özyörük; Suna Emir; Hacı Ahmet Demir; Gülşah Bayram Kabaçam; Bahattin Tunç
Journal:  World J Pediatr       Date:  2016-11-23       Impact factor: 2.764

5.  Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study.

Authors:  Takanori Fukuta; Noriko Nishimura; Yuko Shirouchi; Norihito Inoue; Hideki Uryu; Yoshiharu Kusano; Yuko Mishima; Masahiro Yokoyama; Naoko Tsuyama; Kengo Takeuchi; Yasuhito Terui
Journal:  Int J Hematol       Date:  2020-01-14       Impact factor: 2.490

6.  Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Christian la Fougère; Walter Hundt; Nicole Bröckel; Thomas Pfluger; Alexander Haug; Bernhard Scher; Marcus Hacker; Klaus Hahn; Maximilan Reiser; Reinhold Tiling
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07-21       Impact factor: 9.236

Review 7.  Oncological imaging: tumor surveillance in children.

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2011-08-17

8.  Surveillance investigations after high-dose therapy with stem cell rescue for recurrent follicular lymphoma have no impact on management.

Authors:  Marco Gerlinger; Ama Z S Rohatiner; Janet Matthews; Andrew Davies; T Andrew Lister; Silvia Montoto
Journal:  Haematologica       Date:  2010-01-27       Impact factor: 9.941

9.  Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.

Authors:  C Y Cheah; M S Hofman; M Dickinson; A Wirth; D Westerman; S J Harrison; K Burbury; M Wolf; H Januszewicz; K Herbert; H M Prince; D A Carney; D S Ritchie; R J Hicks; J F Seymour
Journal:  Br J Cancer       Date:  2013-06-27       Impact factor: 7.640

10.  SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.

Authors:  Mariana Bastos Oreiro; Reyes Martín; Pilar Gomez; Nieves López Muñoz; Antonia Rodriguez; Marta Liébana; Belén Navarro; Blanca Sánchez-González; Pilar Marí; Jaime Pérez de Oteiza; Antonio Gutiérrez; Leyre Bento; Eva Domingo Doménech; María Jesús Vidal; Raquel Del Campo; Elena Pérez Ceballos; María Infante; Alicia Roldán; Daniel García Belmonte; Miriam Santero; Anna Sureda; Ramón García Sanz
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.